Citi: Maintains "Buy" rating on BYD COMPANY (01211), target price HK$114
Citi analyzed that BYD COMPANY's pricing remains stable in major overseas markets, but dealer discounts have slightly widened.
Citi issued a research report noting that as of the end of October 2026, battery electric vehicles accounted for 50.9% of BYD COMPANY (01211)'s export sales; during the same period, the blended suggested retail price of BYD Company Limited's globally exported models was RMB337,000, up 3% month-on-month. The bank maintained its "Buy" rating on BYD Company Limited with a target price of HK$114.
According to the bank's field research findings, in the UK market, the official price of the Atto 3 remained at approximately GBP37,000, with dealer discounts of 7%, up slightly 0.2 percentage points from last month; the official price of the Dolphin was stable at approximately GBP25,500, with dealer discounts of 6.9%, up 0.4 percentage points from last month.
In the Australian market, the official price of the Atto 3 was approximately AUD49,000, with dealers offering a 7.6% discount, up 0.3 percentage points from last month; the official price of the Dolphin was approximately AUD36,900, with dealer discounts of 7.3%, also up 0.3 percentage points from last month.
In the Brazilian market, the official price of the Atto 3 remained at BRL229,800, with dealers offering a 10% discount, up 0.4 percentage points from last month; the official price of the Dolphin was BRL149,800, with dealer discounts also at 10%, up 0.7 percentage points from last month.
Citi analyzed that BYD Company Limited's pricing in major overseas markets remained stable, but dealer discounts widened slightly.
Related Articles

Roche (RHHBY.US) Launches Brand Battle Ahead of New Drug Approval! Wilserdly Targets the US$10 Billion Breast Cancer Treatment Market

Morgan Stanley: Reduced regulatory risk has a positive impact on Chinese optical module companies

HK Stock Market Move | CHERVON (02285) falls over 9% after being sued in the US by TECHTRONIC IND for poaching and misappropriation of trade secrets.
Roche (RHHBY.US) Launches Brand Battle Ahead of New Drug Approval! Wilserdly Targets the US$10 Billion Breast Cancer Treatment Market

Morgan Stanley: Reduced regulatory risk has a positive impact on Chinese optical module companies

HK Stock Market Move | CHERVON (02285) falls over 9% after being sued in the US by TECHTRONIC IND for poaching and misappropriation of trade secrets.






